Clinical trials in Noord-Holland

Clinical trial activity in Noord-Holland focuses on cardiovascular diseases, with research centered on atherosclerotic cardiovascular disease and elevated lipoprotein(a). These studies are designed to assess whether new approaches can reduce major heart-related events and improve protection against serious complications.

• Research on atherosclerotic cardiovascular disease and related risk reduction
• Studies in elevated lp(a) to address a key cardiovascular risk factor
• Evaluation of new treatment strategies aimed at preventing major adverse cardiovascular outcomes

Overall, this area of research is helping clarify how emerging therapies may lower the burden of heart attack, stroke, and other urgent cardiovascular events.

The local trial portfolio also covers nutritional and metabolic diseases, especially obesity and overweight. The research is aimed at understanding whether new therapies can support better long-term health outcomes for people living with excess body weight and related risks.

• Obesity and overweight as the main conditions under study
• Assessment of therapies that may improve cardiovascular and kidney-related outcomes
• Research focused on reducing complications linked to metabolic health

These studies reflect a broader effort to evaluate treatments that may help improve both weight-related and organ-protection outcomes in adults.